J&J vaccine production could restart in U.S. 'within days,' Emergent executive testifies
J&J vaccine production could restart in U.S. 'within days,' Emergent executive testifies POLITICO 5 hrs ago By Sarah Owermohle © Stefani Reynolds/The New York Times via AP, Pool Robert Kramer, president and CEO of Emergent BioSolutions, speaks via videoconference during a hearing on Capitol Hill. Emergent BioSolutions could resume manufacturing Johnson & Johnson's Covid-19 vaccine within days, CEO Robert Kramer told a House panel Wednesday. The Food and Drug Administration ordered Emergent to pause production last month after a series of manufacturing problems at its Balt...
Source: msn.com